RESUMEN
This work is focused on the mass transport of methanol and the methanol-assisted crack healing in poly(methyl methacrylate) (PMMA)-graphene composites at different temperatures. The effect of the fraction of graphene on the mass transport of methanol and the methanol-assisted crack healing is also studied. The experimental results reveal that adding graphene to the PMMA matrix increases the resistance to the migration/diffusion of methanol and polymer chains in the PMMA matrix, and the absorption of methanol follows anomalous diffusion. The activation energies for the case I transport and case II transport in the PMMA-graphene composites are relatively independent of the fraction of graphene, and are larger than the corresponding ones in pure PMMA. Increasing the healing time and healing temperature allows for more polymer chains to migrate/diffuse across fractured surfaces, leading to the increase in the fracture strength of the crack-healed PMMA-graphene composites.
RESUMEN
OBJECTIVE: To establish a chromatography-based method for simultaneous analysis of the concentrations of amoxicillin and clavulanate potassium in human blood. METHODS: With paracetamol as the internal control, human plasma samples, after treatment with methanol for protein sedimentation and centrifugation, were loaded for analysis with high-performance liquid chromatography (HPLC). HPLC analysis was carried out using a C18 column (5 µm, 4.6 mm×150 mm) with the mobile phase of acetonitrile-PBS (0.05 mol/L) of 10:90 (pH 2.3), UV detection wavelength of 220 nm, flow rate of 1.0 ml/min, and column temperature of 25 degrees celsius;. RESULTS: The retention time of acetaminophen for potassium clavulanate, amoxicillin sodium and the internal control was 5.3, 7.2, and 8.5 min, respectively, and no interference by the endogenous impurities in the plasma samples was found. Amoxicillin sodium showed a good linearity within the concentration range of 0.52-4.16 µg/ml (r(2)=0.9996), and potassium clavulanate had a good linearity within the range of 0.266-2.14 µg/ml (r(2)=0.9998). The minimum detectable concentrations of amoxicillin sodium and potassium clavulanate were 0.065 µg/ml and 0.066 µg/ml, respectively. The relative recoveries of amoxicillin sodium were 95.9%-96.5% (n=5), and those of clavulanate potassium were 92.5%-98.8% (n=5); the intra- and inter-day RSD of amoxicillin sodium was 1.84%-6.4% and 2.1%-7.8%, as compared to that of potassium clavulanate of 3.57%-8.6% and 1.8%-9.1%, respectively. CONCLUSION: This method is simple, accurate, sensitive, specific and reproducible for analyzing the concentrations of amoxicillin and clavulanate potassium simultaneously in human plasma.